National Advisory Committee on Immunization (NACI): Membership and representation

CHU Sainte-Justine, University of Montréal
Montréal, Quebec

Dr. Caroline Quach is a Professor in the Departments of Microbiology, Infectious Diseases Immunology and Pediatrics at Université de Montréal and the physician in charge of the Infection Prevention & Control Unit at the CHU Sainte-Justine. She works as a pediatric infectious diseases consultant and a medical microbiologist. She holds a cross-appointment at the Quebec Institute of Public Health (INSPQ) where she works in the Healthcare-Associated Infections and Immunization branches.

Dr. Quach graduated from the Université de Montréal Medical School, completed her pediatric residency training at the CHU Sainte-Justine, and her post-graduate training at McGill University. She is a clinician-investigator and holds a salary award from the Fonds de recherche du Québec - Santé (FRQS, mérite). She holds a Tier 1 Canada Research Chair in Infection Prevention. Her research interests are focused on the prevention of infections - both healthcare-associated infections and vaccine-preventable diseases.

Dr. Quach is the former president of the Association of Medical Microbiology and Infectious Disease - Canada's (AMMI). She is the former chair of theQuebec Immunization Committee (CIQ) and is the current chair ofthe National Advisory Committee on Immunization (NACI).

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humansthat do not fit in the categories above?

Please provide any additional comments, if applicable:

Office of the Chief Medical Officer of Health
Halifax, Nova Scotia

Dr. Shelley Deeks is the Public Health Surveillance Medical Officer of Health at the Nova Scotia Office of the Chief Medical Officer of Health. She has a long-standing interest and passion for communicable disease control and immunization in general, and vaccine safety in particular, with over 120 peer-reviewed publications. Aside from her membership in the National Advisory Committee on Immunization, she is a past Chair of the World Health Organization's (WHO's) Immunization Practices Advisory Committee. Dr. Deeks holds Fellowships in Public Health in both Canada and Australia and completed the Canadian Field Epidemiology Program. She has over 20 years' experience as a public health physician and has worked at all levels of the public health system in Canada, and at the national level in Australia.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

University of British Columbia
Vancouver, British Columbia

Dr. Julie Bettinger is an Associate Professor at the Vaccine Evaluation Center in the Department of Pediatrics at the University of British Columbia. She is an infectious disease epidemiologist whose research interests include vaccine safety and vaccine preventable diseases (specifically meningococcal and pneumococcal invasive infections), as well as attitudes and beliefs around immunization uptake and use. She is the data center director for the Canadian Immunization Monitoring Program, Active (IMPACT), an active surveillance network for vaccine preventable diseases and vaccine adverse events in 12 tertiary care pediatric hospitals across Canada and the principal investigator for CIRN's Canadian National Vaccine Safety (CANVAS) network, which monitors the safety of influenza vaccines each year.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

Children's Hospital of Eastern Ontario (CHEO)
Ottawa, Ontario

Natalie Dayneka is a clinical specialist with the Pharmacy Department of the tertiary care pediatric teaching hospital, Children's Hospital of Eastern Ontario (CHEO). As a pediatric pharmacist, Natalie has played an active role developing pediatric guidelines for Infectious Diseases, including Immunizations. She was a co-author of the online 2015 CHEO Antimicrobial Guidelines for Children which has been offered externally as a mobile application (APP) for pediatric practitioners across Canada.

Natalie has consulted on other federal committees and was a member of the Pharmacology and Therapeutics Committee for the First Nations and Inuit Health Programs Directorate. She also served on the Canadian Paediatric Society's Drug Therapy and Hazardous Substances Committee. More recently, Natalie served on the Ontario Quality Based Procedure Tonsillectomy Clinical Expert Advisory Group.

Natalie has been very active with the Canadian Society of Hospital Pharmacists (CSHP) and was awarded the title of Fellow. She is a past Chair of the Canadian HIV/AIDS Pharmacists Network (CHAP). Natalie has presented lectures and posters at regional, national and international meetings.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

Département de médicine sociale et préventive
Québec, Quebec

Philippe De Wals is Professor at the Department of Social and Preventive Medicine, Laval University, in Québec City, Canada. Professor De Wals gained his Medical Degree and a Doctorate in Public Health in his home country of Belgium, at the Louvain Catholic University. His early academic and professional career combined epidemiology research studies at the School of Public Health at the Louvain Catholic University with the practice of general medicine. Between 1980 and 2000 he worked as an epidemiologist for EUROCAT, a European network of population-based registries for the epidemiologic surveillance of congenital anomalies. In 1990, he moved to Canada and became the Head of the Department of Community Health Sciences at the University of Sherbrooke. In 1997, he was appointed visiting Professor at the School of Public Health at the University of North Carolina in Chapel Hill, USA.

Professor De Wals' research is centered on the epidemiology of infectious diseases, reproductive abnormalities, and the assessment of health services and public health programs and policies. He is the author of over 150 published articles in scientific journals and has contributed several chapters to textbooks. Currently, Professor De Wals is a member of the research centers at Quebec University Hospital and the Sherbrooke University Hospital and is a medical advisor to the Quebec National Institute of Public Health. In 2011, he was appointed as Scientific Director of the Evaluation Platform on Obesity Prevention at the Quebec Cardiology and Pneumology Institute.

In 1990, Professor De Wals was awarded the Jean Van Beneden Prize in recognition of his excellent work in the public health field, and in 2005, he was elected to the Royal Academy of Medicine of Belgium.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

All the research programs described are investigator-initiated grants in which sponsors have no control on the study design, collection, analysis and interpretation of date, and dissimination of results.

I am also co-investigator or collaborator in several research projects supported by recognized research funding organizations (i.e. IRSC, FQRS).

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

No honorarium associated with these activities

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

I wrote scientific papers and reports, participated in the elaboration of statements (i.e. NACI and CIQ), gave presentations and lectures on vaccines that were totally independent from pharmaceutical companies.

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

Québec National Institute of Public Health and the Research Center of the CHU-Québec
Québec, Quebec

Eve Dubé is a medical anthropologist. She is affiliated with Quebec National Institute of Public Health and the Research Center of the CHU-Québec. She is also an invited professor in anthropology at Laval University. Her research focuses on social, cultural and ethical issues around infectious diseases prevention. Most of her research aims at understanding why people accept, refuse or hesitate to receive vaccines and why healthcare providers adhere or not to vaccination recommendation for themselves, their families and their patients. She is the lead investigator of the Social Sciences and Humanities Network of the Canadian Immunization Research Network. From 2013 to 2014, she was a member of the World Health Organization (WHO) working group on vaccine hesitancy and she is currently part of the WHO Global Advisory Committee on Vaccine Safety where she is mainly involved in vaccine risk communication.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

Toronto Public Health

Dr. Vinita Dubey graduated from the University of Toronto's Public Health and Preventive Medicine Residency Program. She holds an Adjunct Professor appointment with the University of Toronto's Dalla Lana School of Public Health. Since 2006, she has been an Associate Medical Officer of Health for Toronto Public Health in Communicable Disease Control. Specializing with the Vaccine Preventable Disease program includes involvement in the school based vaccine program, immunization school assessment program which suspends students who are not up-to-date with required vaccines, adverse event following immunization investigations, and outbreak management including the 2017 mumps outbreak in Toronto which was the largest mumps outbreak the city has had in over 20 years. She also works as an emergency medicine physician in a small community hospital.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

University of Montreal
Montreal, Quebec

Dr. Soren Gantt is a Professor in the Departments of Microbiology, Infectious Diseases Immunology and Pediatrics at Université de Montréal, and a Pediatric Infectious Diseases consultant and the Director of Clinical Research at CHU Sainte-Justine. Dr. Gantt obtained his MD and PhD (Immunology) degrees from the New York University School of Medicine. He completed his Pediatrics residency and Infectious Diseases fellowship at Seattle Children's Hospital and the University of Washington, where he also obtained an MPH (Epidemiology). He is the former Head of Pediatric Infectious Diseases and Director of Clinical Research at BC Children's Hospital. His research combines translational studies and clinical trials, with a focus on the pathogenesis and prevention of disease due to cytomegalovirus and other human herpesviruses.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

Alberta Health Services
Grey Nuns and University of Alberta Hospitals

Dr. Robyn Harrison is an Infectious Disease Specialist who works in Edmonton, Alberta. She is a Communicable Disease Consultant for the province wide Alberta Health Services Workplace Health and Safety Program (a position she has held since 2009). She has also served as consultant for the Covenant Health Alberta Occupational Health and Safety Program (2008-2014). Dr. Harrison is keenly interested in policy development and support for clinicians to prevent infection transmission in healthcare settings. She is a member of the Alberta Advisory Committee on Immunization, and she participates in infection prevention working groups in the province of Alberta, including past work on pandemic influenza H1N1 in 2009, and avian influenza is 2014. At a national level, she is working with the Public Health Agency of Canada as a member of the Prevention and Control of Occupational Infections in Health Care Settings Guideline Working Group to update and disseminate national evidence-based infection prevention and control (IPC) guidance.

Dr. Harrison obtained her medical degree at Dalhousie University, Nova Scotia; and she completed her Internal Medicine and Infectious Diseases subspecialty training at the University of Alberta. Most recently she completed an MSc in the combined areas of Public Health and Epidemiology through the London School of Hygiene and Tropical Medicine, England.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

University of British Columbia
Vancouver, Bristih Columbia

Dr. Kyla Hildebrand is a Pediatric Clinical Immunology and Allergy specialist and Clinical Associate Professor in the Department of Pediatrics at the University of British Columbia (UBC). Her subspecialty training was completed at the Hospital for Sick Children and University of Toronto. She completed a Master of Community Health Sciences program from the Dalla Lana School of Public Health, University of Toronto. She is a Clinical Investigator at the BC Children's Hospital Research Institute and Director of the Pediatric Clinical Immunology and Allergy Residency Training Program at UBC.

Dr. Hildebrand's clinical work involves assessing and managing complex patients presenting with allergic and immunological disorders including children requiring hematopoietic stem cell transplantation. She has been engaged with the Special Immunization Clinic (SIC) Network at UBC since 2014. She is a collaborator at the UBC site in the Canadian Health Infant Longitudinal Development (CHILD) study, designed to advance knowledge about the genetic and environmental determinates of atopic disease to determine how early life exposures relate to health and disease outcomes.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

Alberta Health Services
Edmonton, Alberta

Dr. Kristin Klein is public health and preventive medicine specialist based out of Edmonton, Alberta. She holds two positions with Alberta Health Services, serving as Associate Provincial Medical Officer of Health for Communicable Disease Control and as a local Medical Officer of Health for Northern Alberta. Her educational background includes a Bachelor of Science from the University of Calgary, a medical degree and fellowship training in Public Health and Preventive Medicine from the University of Alberta. Prior to her role with AHS, Dr. Klein served as the Deputy Medical Officer of Health for the Government of Alberta. She has contributed to several provincial and national committees including representing the Council of Chief Medical Officers of Health as liaison member to NACI. She also holds a clinical appointment with the Faculty of Medicine and Dentistry at the University of Alberta.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

McGill University Health Centre
Montreal, Quebec

Dr. Jesse Papenburg is an Assistant Professor of Pediatrics and an Associate Member of the Department of Epidemiology, Biostatistics and Occupational Health at McGill University. He practices Pediatric Infectious Diseases and Medical Microbiology at the Montreal Children's Hospital of the McGill University Health Centre.

Dr. Papenburg obtained his medical degree from McGill University and completed residency and subspecialty training at the Montreal Children's Hospital. He then completed a research fellowship on the molecular virology of RNA respiratory viruses at Laval University and a MSc in epidemiology at McGill. As a clinician scientist, Dr. Papenburg's research is on the epidemiology of viral respiratory infections, with a focus on diagnostics to improve treatment and outcomes. He actively contributes to national and provincial guidelines on RSV immunoprophylaxis and influenza antiviral treatment.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

University of Toronto and University Health Network
Toronto, Ontario

Dr. Rotstein is Professor of Medicine in the Division of Infectious Diseases at the University of Toronto and Attending Physician at the University Health Network, Toronto, Ontario. He received a Bachelor of Science at the University of Toronto and earned his medical degree from the University of Calgary in 1976. Dr. Rotstein completed his specialty training in Internal Medicine at the University of Toronto and pursued further subspecialty training in Infectious Diseases & Immunology at the Medical University of South Carolina in Charleston, South Carolina from 1980 to 1983 [ABIM (1980), FRCPC (Internal Medicine 1981), Infectious Diseases ABIM (1982)].

Dr. Rotstein is currently the Director of Oncologic Infectious Diseases at Princess Margaret Cancer Centre of the Immunocompromised Host Infectious Diseases Service at the University Health Network. He is also former Director of the Division of Infectious Diseases at McMaster University, past Chair and Secretary of the Infectious Diseases Section of the Ontario Medical Association, former Co-chair of the Emerging Infectious Diseases Network, former Past-President of the Association of Medical Microbiology and Infectious Disease Canada, former President of the Canadian Infectious Disease Society, and former Chair of the Clinical Trials Committee of the Canadian Infectious Disease Society. In addition, he has been elected a fellow of the American College of Physicians and the Infectious Diseases Society of America. He is a reviewer for several international journals and was formerly Associate Editor, Review Section, for the Canadian Journal of Infectious Diseases and Medical Microbiology.

Dr. Rotstein has published over 160 peer-reviewed papers. His research interests have focused mainly on infections in cancer patients and other immunocompromised hosts as well as fungal infections caused by Candida organisms. He maintains active research interests in clinical trials involving antifungal agents in immunocompromised hosts.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

Toronto General Hospital
Toronto, Ontario

Beate Sander, PhD, is a Scientist at Public Health Ontario (PHO), Assistant Professor at the University of Toronto, Adjunct Faculty at York University, and Adjunct Scientist at the Institute for Clinical Evaluative Sciences (ICES).

Beate's research interests lie in the area of economic evaluation with a focus on infectious diseases. She is leading multidisciplinary teams evaluating Zika and West Nile virus mitigation strategies using data-driven simulation models, and is linking laboratory with population-based administrative data, enabling novel approaches to study the burden of infectious diseases.

Beate served on the board of the Society of Medical Decision Making (SMDM) and is an editorial board member of the "Medical Decision Making" journal. Beate provides scientific advice to decision-makers and advisory bodies and serves on scientific working groups and networks.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

Alberta Health
Edmonton, Alberta

Ms. Smith is the Manager for Immunization Policy at Alberta Health. She has over thirty years of Public Health experience primarily focused on public health programs, immunization, and communicable disease control. Her roles have included front line generalist practice, nurse consultant, clinical development nurse (immunization and communicable disease control), and manager for immunization policy at Alberta Health.

Her experience includes providing immunizations, orienting/educating staff and clients on immunization and communicable disease issues, ensuring quality of immunization programs, and following up on notifiable diseases providing her with a strong clinical and operational background in public health immunization programs.

Currently, as manager for immunization policy Ms. Smith is responsible for the development and implementation of immunization policy in Alberta. This includes, coordinating and facilitating the work of the Alberta Advisory Committee on Immunization. In addition, in this role she has chaired and facilitated a number of immunization working groups comprised of medical officers of health, infectious disease physicians, nurse leaders and program staff to update and revise Alberta's immunization policy including immunization recommendations for solid organ transplant recipients, hematopoietic stem cell transplant recipients, and immunocompromised individuals; and recommendations for rotavirus, hepatitis B, varicella, and measles containing vaccines.

Ms. Smith has also been a member of in the Canadian Nursing Coalition for Immunization for the past two years and presented at the 2016 Canadian Immunization Conference.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

The Alberta Advisory Committee on Immunization (the Committee) is a multidisciplinary expert committee, reporting to the Deputy Minister of Health through the Chief Medical Officer of Health, with the mandate to provide ongoing and timely medical, scientific and public health advice related to immunization

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

Alberta Health is my place of employment.  My major responsibility is ensuring Alberta's immunization policy is current through review of current literature, research, and consultation.  As well, as responding to health care professional inquiries on Alberta's Immunization Policy. Within the manager role is the responsibility to the Alberta Advisory Committee on Immunization as secretariat.

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

All immunization policies are published on the web https://www.alberta.ca/alberta-immunization-policy.aspx

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

Public Health Ontario
Toronto, Ontario

Dr. Sarah Wilson is a public health physician/medical epidemiologist at Public Health Ontario PHO where she works closely with the Immunization and Vaccine-Preventable Diseases team within the Communicable Diseases and Emergency Preparedness Response Department. In this role, she provides support to the surveillance of vaccine-preventable diseases, immunization coverage, vaccine safety, outbreak management, and participates in applied research. Sarah's research interests include applied vaccine program evaluation and immunization coverage assessment using a range of data sources including both routine surveillance and administrative data. She is a Fellow of the Royal College of Physicians and Surgeons in Public Health and Preventive Medicine and a graduate of the Canadian Field Epidemiology Program. She is an Assistant Professor at the Dalla Lana School of Public Health at the University of Toronto and an Adjunct Scientist at ICES (formerly known as the Institute for Clinical Evaluative Sciences).

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

I am listing my affiliation with the University of Toronto Centre for Vaccine-Preventable Diseases here as I understand the Centre has recently received funding from vaccine manufacturers to support post-doctoral fellowships that would be funded through the Centre. I will not be involved in the administration of the funds and will not receive any of the funds. I am unsure of the specific dollar amount as a formal announcement is forthcoming.

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2.  Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

I receive a salary as an employee of Public Health Ontario. My role at Public Health Ontario includes providing scientific and technical advice to the Ontario Ministry of Health in regards to the implementation and monitoring of immunization programs.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

I have never received speaking fees for any presentations/lectures. I have received travel honorariums for conferences and lectures, but never any funds from a pharmaceutical company or related third party.

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

I have received funds from WHO for travel to conferences and meetings, and travel honorariums from conferences directly, but never any funds from a pharmaceutical company or related third party.

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

No personal financial benefit of participation. I am not the holder of these funds.

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

I do routinely give presentations in the CME category for a variety of audiences including family physicians and other immunization service providers.

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

I am a full-time employee of the University of British Columbia funded by the BC Centre for Disease Control in a grant tenure position. I am full faculty at UBC and a Professor. My full-time service role with BCCDC is as the Medical Director of the Communicable Diseases and Immunization Service and Medical Head for Immunization Programs and Vaccine Preventable Diseases.  All of the activities listed above are in the context of these positions.

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

Immunize Canada receives sponsorships and educational grants from various pharmaceutical companies to undertake it's educational and promotional activities. These funds go towards the operation of the coalition and Immunize Canada retains editorial control over all its' products. These grants and sponsorships are obtained on a yearly basis.

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

Receive $1000.00 honorarium (for all three) and travel expenses

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:
Reimbursement for registration fees and travel expenses

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactc agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

2016 Canadian Immunization Conference - presentation on Security of Vaccine Supply

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

Please provide any additional comments, if applicable:

Part of my duties in the role of Chief Medical Health Officer for Fraser Health (August 2017- July 2020) was being an official spokesperson on public health issues. I spoke to the media on a regular basis. During media interviews, we refrain from using brand names, but we do promote immunization in general and often specifically mentioning vaccine products generically.

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

3. Intellectual property

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Please provide any additional comments, if applicable:

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

Please provide any additional comments, if applicable:

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

7. Hospitality

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

Please provide any additional comments, if applicable:

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic